3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
UNKNOWN
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
24
Prostatic Neoplasms
16
Sarcoma
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
5
Uterine Cervical Neoplasms
4
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Liposarcoma, Myxoid
3
Head and Neck Neoplasms
3
Glioblastoma
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Radiation Injuries
2
Pancreatic Neoplasms
2
Neurofibrosarcoma
2
Neoplasms
2
Melanoma
2
Lymphatic Metastasis
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Advanced Refractory Solid Tumors
2
Uterine Neoplasms
1
Urothelial Cancer
1
Urogenital Neoplasms
1
Interventions
Radiosurgery
114
Temozolomide
104
Bevacizumab
71
Radiotherapy
67
Magnetic Resonance Spectroscopy
67
Carboplatin
29
pembrolizumab
28
Irinotecan
26
Surgical Procedures, Operative
25
Radiation
23
Nivolumab
23
Etoposide
22
Magnetic Resonance Imaging
21
Ipilimumab
21
Erlotinib Hydrochloride
21
Cyclophosphamide
21
Surveys and Questionnaires
19
Aminolevulinic Acid
18
Specimen Handling
16
Pemetrexed
16
Mental Status and Dementia Tests
16
Cisplatin
16
Carmustine
15
Topotecan
14
Trastuzumab
13
Saline Solution
12
Neuropsychological Tests
12
Gefitinib
11
Filgrastim
11
Drug Therapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Brain Neoplasms
×
Radiation Dose Hypofractionation
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled